← Search

Data · dataset · 2026

Vascularization of Human iPSC-Derived Kidney Organoids Using Perfusion Culture, Pre-Vascularized Collagen Scaffolds, and Decellularized Extracellular Matrix

Listed in IISH Dataverse

Human induced pluripotent stem cell-derived kidney organoids represent promising in vitro models for studying kidney development and drug-induced toxicity, yet their lack of vasculature limits maturation and translational use.

Description

Here, we present a proof-of-concept co-culture platform to promote vascularization of kidney organoids by integrating stromal vascular fraction cells, collagen sponge scaffolds, porcine kidney decellularized extracellular matrix (dECM), and dynamic culture in a perfusion-based U-CUP bioreactor.

We systematically evaluated the effects of serum supplementation, scaffold pre-vascularization, dECM encapsulation, and flow conditions on organoid–vascular integration. Low-level serum supplementation (1.5% FBS) sustained vascular networks without compromising organoid morphology. Perfusion supported vascular expansion; however, while a low flow rate comparable to interstitial tissue flow (0.01 mL/min) preserved organoid morphology and glomerular-like structures, a higher flow rate optimized for vascularization (0.47 mL/min) disrupted overall organoid architecture.

Read the rest (1 more)

Encapsulation within dECM preserved glomerular morphology and supported vascular infiltration, whereas co-culture with stromal vascular fraction cells enabled putative podocyte–endothelial interactions. Finally, exposure to the calcineurin inhibitor tacrolimus revealed dose-dependent cytotoxicity and characteristic nephron and vascular injury, demonstrating the model’s utility for nephrotoxicity screening. The established modular platform enables the engineering of vascularized kidney organoids, establishing foundations for physiologically relevant models for disease modeling and pre-clinical drug testing.

Links

Where it is published

Catalogue records · 1

Topics

Inferred from text
Disease 75% · Medical biotechnology 70%
Provenance · 1 source records, 11 field assertions
SourceKeyLast seenRaw
IISH Dataversedoi:10.34894/NVTCCT13 d agoJSON v1
FieldAssertionExtractorEvidence
concepts[disease].local:disease:diseaseenrichment · datasets iisg amsterdamkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].anzsrc:group:3206enrichment · datasets iisg amsterdamtaxonomy-embedding@1.1.0title+keywords+description (70%)
concepts[field].dataverse_subject:medicine-health-and-life-sciencessource · datasets iisg amsterdamconnector:datasets_iisg_amsterdam@1.0.0/subjects
concepts[field].local:field:life-sciencesmapping · datasets iisg amsterdamconnector:datasets_iisg_amsterdam@1.0.0/subjects
concepts[field].local:field:medicine-healthmapping · datasets iisg amsterdamconnector:datasets_iisg_amsterdam@1.0.0/subjects
created_datesource · datasets iisg amsterdamconnector:datasets_iisg_amsterdam@1.0.0
descriptionsource · datasets iisg amsterdamconnector:datasets_iisg_amsterdam@1.0.0/description
publication_datesource · datasets iisg amsterdamconnector:datasets_iisg_amsterdam@1.0.0
titlesource · datasets iisg amsterdamconnector:datasets_iisg_amsterdam@1.0.0/name
updated_datesource · datasets iisg amsterdamconnector:datasets_iisg_amsterdam@1.0.0
version_labelsource · datasets iisg amsterdamconnector:datasets_iisg_amsterdam@1.0.0